Fig. 3From: Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancerKaplan–Meier curves of overall survival based on the level of residual disease after SCS (a), preoperative cancer antigen 125 (CA-125) levels (b), platinum-free interval (c), surgery type (d), histology (e), and American Society of Anaesthesiologists (ASA) score (f)Back to article page